45The relationship between Plasmodium falciparum gametocyte density and infections in mosquitoes is 46 central to understanding the rates of transmission with important implications for control. Here, we 47 determined whether field relevant variation in environmental temperature could also modulate this 48 relationship. Anopheles stephensi were challenged with three densities of P. falciparum gametocytes 49 spanning a ~10-fold gradient, and housed under diurnal/daily temperature range ("DTR") of 9⁰C around 50 means of 20⁰C, 24⁰C and 28⁰C. At the peak stages of infection for each temperature, the proportion of 51 mosquitoes infected with oocysts in the midguts or infectious with sporozoites in the salivary glands were 52 measured (referred to collectively as vector competence hereon), in addition to oocyst intensities from 53 infected midguts. While vector competence was similar at 20 DTR 9⁰C and 24 DTR 9⁰C, the proportion 54 of mosquitoes infected and subsequently infectious were also comparable, with evidence, surprisingly, for 55higher vector competence in mosquitoes challenged with intermediate gametocyte densities. For the same 56 gametocyte densities however, severe reduction in the proportion of infectious mosquitoes was 57 accompanied by a significant decline in vector competence at 28 DTR 9⁰C, although density per se 58 showed a positive and linear effect at this temperature. Unlike vector competence, oocyst intensities 59 decreased with increasing temperatures with a predominantly positive and linear association with 60 gametocyte density, especially at 28 DTR 9⁰C. Oocyst intensities across individual infected midguts 61suggested temperature-specific differences in mosquito susceptibility/resistance : at 20 DTR 9⁰C and 24 62 DTR 9⁰C, dispersion (aggregation) increased in a density-dependent manner but not at 28 DTR 9⁰C where 63 the distributions were consistently random. Limitations notwithstanding, our results have manifold 64 implications in, for instance, how variation in temperature could modify seasonal dynamics of infectious 65 reservoirs and transmission and the contribution of high-/patent-and low-density/sub-patent carriers, to 66 suggestions for design and deployment of transmission-blocking vaccines/drugs, but with a cautionary 67 note suggesting how low efficacy could lead to transmission enhancement in certain environments.